ArticleCell reports. Medicine2024

PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers.

Yiqian Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.